American Society of Hematology

Annual Meeting Registration

Advance registration for the 56th ASH® Annual Meeting is now open.

Learn more

ASH Academy

Now offering malignant and non-malignant hematology testing modules that provide both MOC and CME credit

Learn more

ASH Foundation 3K - 5K Run/Walk

December 7, 2014 - run or walk in the ASH Foundation 3K - 5K Run/Walk and help move hematology forward.

Learn more

Protect Medical Research

Urge Congress to find a balanced approach to deficit reduction that does not involve further cuts to biomedical research.

Take action
Find a Hematologist

Find a Hematologist

Search a database of practicing hematologists in your area.

Learn more
Support Hematology

ASH Foundation

Help move hematology forward by supporting research, career development, and quality care and education programs.

Learn more
Join ASH

ASH Membership

Become part of a global network of more than 16,000 hematologists working to conquer blood diseases.

Learn more
  • The American Society of Hematology Elects New Leadership

    The American Society of Hematology (ASH), the world’s largest professional society concerned with the causes and treatment of blood disorders, today announced the election of four new members to its Executive Committee, the governing body of the organization, for terms beginning after the 2014 ASH Annual Meeting December 6-9 in San Francisco.

  • ASH Statement on Inaugural World Thrombosis Day

    The American Society of Hematology (ASH), the world’s largest professional society concerned with the causes and treatment of blood disorders, today joins the International Society on Thrombosis and Haemostasis (ISTH) and nearly 200 organizations worldwide to commemorate October 13, 2014, as the inaugural World Thrombosis Day, a day dedicated to raising awareness of potentially dangerous blood clots.

  • Statement from ASH President Linda J. Burns, MD, on Release of Sunshine Act Data

    Today the Centers for Medicare & Medicaid Services released a large set of data about the payments physicians and teaching hospitals received from pharmaceutical and medical device companies from August 1 to December 31, 2013.

  • Fellows and Junior Faculty Participate in 12th ASH Clinical Research Training Institute

    The American Society of Hematology (ASH) today announced the names of the 21 hematology trainees selected to participate in the 12th annual ASH Clinical Research Training Institute (CRTI). This education and mentorship program is designed to prepare current hematology and hematology/oncology fellows and junior faculty for careers in patient-oriented clinical research.

View all press releases
  • Ebola Alert

    The Department of Health and Human Services' Centers for Disease Control and Prevention (CDC) and Office of the Assistant Secretary for Preparedness and Response (ASPR) continues to respond to the current Ebola outbreak in West Africa. The CDC has summarized key messages about the outbreak and the response, and it will continue to update its resources as more information becomes available.

  • Sunshine Data Released – What’s Next?

    On September 30 at around 2PM, the Centers for Medicare and Medicaid Services (CMS) publicly released the data that it had been gathering from pharmaceutical and medical device companies that detail value transfers to physicians and medical schools.  ASH has been keeping members apprised of these developments since this provision was included in the Affordable Care Act.

  • Least Costly Alternatives for Drugs in the World of Hematology

    The Medicare Payment Advisory Commission (MedPAC) used its second session of the 2014-2015 cycle to take on an issue that could be very important for hematologists and access to drugs for their patients–the opportunity for Medicare to pay for drugs on a “least costly alternative” basis.  ASH continues to follow this issue as part of a commitment to ensure that policies are created that give patients efficient access to important drugs while maintaining clinician decision-making and incentives for continued innovation.

  • Medicaid Pay Parity Nears Expiration – ASH Works with ACP to Extend

    Since the passage of the ACA, specialists in internal medicine—including hematologists—have been eligible for increased Medicaid payment rates. The ACA, however, limited this increase in payment to 2013 and 1014, and the rates will soon revert to their former levels without further legislation. ASH has worked with the American College of Physicians and other stakeholders to support legislation that would extend this payment parity, and has recently submitted a letter to further show support.

View all policy news
View all Hematologist articles